The phosphorylation of CRMP2 (pCRMP2) is linked to several neurological dysfunctions, such as Alzheimer’s disease (AD) and spinal injury (Cole et al., 2007; Menon et al., 2011; Petratos et al., 2012; Yoshida et al., 1998; Zhao et al., 2020). This evidence concerns the gene DPYSL2 and Alzheimer disease.